* SHELL: Shell delivered a record $40 billion profit in 2022, capping a tumultuous year in which Russia's invasion of Ukraine allowed the energy giant to hand shareholders unprecedented returns.
* ANGLO AMERICAN: Anglo American Plc said its
fourth quarter production rose 10%, supported by copper output at its Quellaveco mine in Peru and strong rough diamond production from De Beers.
* BT: BT stuck to its full-year outlook
despite the pressure of high energy costs and other inflationary headwinds,
as it reported a 3% dip in third-quarter adjusted revenue, just below market
expectations.
* SUPERDRY: The founder and chief executive of Superdry has
no plans to take the group private "at the moment", he said.
* CRANSWICK: Cranswick said
trading was robust in December, helped by sustained demand for fresh pork and gourmet festive ranges.
* BNZL: Bunzl Plc said it
signed a contract with its largest customer by revenue to continue to support distribution services across the United States.
* GSK: The U.S. FDA approved GSK Plc's drug as the first oral
treatment for anemia caused by chronic kidney disease in adults.
* UK PHARMA: UK's pharmaceutical trade body called for the government to
scrap its plans to raise the repayment rates for drugmakers.
* BOE: The Bank of England is poised to raise interest rates for the 10th
time in a row to keep up its fight against rampant inflation.
* For more on the factors affecting European stocks, please click on: TODAY'S UK PAPERS
> Financial Times > Other business headlines (Reporting by Sruthi Narasimha Chari in Bengaluru)
